Last reviewed · How we verify
Probiotic Combination Cap/Tab
A probiotic combination restores beneficial gut microbiota to improve intestinal health and immune function.
Seoul National University Bundang Hospital's Probiotic Combination Cap/Tab is under investigation for various conditions including SIBO, IBS, radiation proctitis, and H. pylori eradication. The drug has completed several clinical trials and shows promise in adjunctive therapy settings.
At a glance
| Generic name | Probiotic Combination Cap/Tab |
|---|---|
| Also known as | The Perfect Probiotics® |
| Sponsor | Seoul National University Bundang Hospital |
| Drug class | Probiotic |
| Modality | Small molecule |
| Therapeutic area | Gastroenterology / Immunology |
| Phase | Phase 3 |
Mechanism of action
Probiotic combinations contain live beneficial bacteria (such as Lactobacillus and Bifidobacterium species) that colonize the gastrointestinal tract, enhance the intestinal barrier function, and modulate the immune system. By restoring a healthy microbiota composition, these formulations may reduce pathogenic bacterial overgrowth, improve nutrient absorption, and support systemic immune responses.
Approved indications
- Gastrointestinal disorders (specific indication not publicly detailed)
- Microbiota restoration and immune support
Common side effects
- Gastrointestinal disturbance (bloating, gas)
- Mild abdominal discomfort
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: